An AI-generated song featuring the cloned vocals of Drake and the Weeknd has officially been submitted for two Grammys.
back in June that "Grammys will only be allowed to go to human creators who have contributed creatively in the appropriate categories," the song is still technically eligible, the"As far as the creative side, it’s absolutely eligible because it was written by a human," Mason told the newspaper this week.
Now, Ghostwriter has turned to two new artists for their next song, a track called "Whiplash" that features the cloned vocals of rappers Travis Scott and Shéyaa "21 Savage" Bin Abraham-Joseph."Me and Writer raise a toast," the AI-generated version of 21 Savage raps. "Trying to shadowban my boy, but you can’t kill a ghost."
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
A.I.-Generated Song That Mimics Drake & The Weeknd Submitted for Grammy ConsiderationGhostwriter, the person behind “Heart on My Sleeve,” also released a new A.I.-generated track that sounds like Travis Scott and 21 Savage.
Read more »
Ghostwriter’s ‘Heart on My Sleeve,’ the AI-Generated Song Mimicking Drake and the Weeknd, Submitted for GrammysA collaborative track featuring AI-generated facsimiles of Drake and the Weeknd’s voices titled “Heart on My Sleeve” has been submitted for Grammy consideration. One caveat: Neith…
Read more »
Drake and The Weeknd AI track submitted to GrammysGhostwriter's song 'Heart On My Sleeve,' which uses AI to mimic Drake and The Weeknd, is the first step to a new AI business plot
Read more »
The Weeknd Boycotting Grammys Citing 'Secret Committees,' Grammys RespondsThe Weeknd says he'll boycott the Grammys moving forward.
Read more »
The Grammys will consider that viral song with Drake and The Weeknd AI vocals for awards after allThe creator of 'Heart on my Sleeve,' a song that used generative AI to mimic the vocals of Drake and The Weeknd, has submitted it for Grammy Award consideration.
Read more »
New AI-generated COVID drug enters Phase I clinical trials: ‘Effective against all variants’Insilico Medicine recently announced that its new AI-designed drug for COVID-19 has entered Phase I clinical trials. If approved, it would become the first-ever alternative to Paxlovid.
Read more »